These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8224740)

  • 1. Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
    Kishi K; Ikeda M
    Gen Pharmacol; 1993 Jul; 24(4):863-6. PubMed ID: 8224740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
    Yaoka O; Aoki K; Nakajima T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
    Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
    Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
    Kubo M; Kato J; Ochiai T; Ishida R
    Jpn J Pharmacol; 1990 Jun; 53(2):201-10. PubMed ID: 2200918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats.
    Okamoto K; Ohta Y; Chikugo T; Shiokawa H; Morita N
    J Hypertens; 1991 Dec; 9(12):1105-17. PubMed ID: 1663966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme.
    Becari C; Teixeira FR; Oliveira EB; Salgado MC
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H565-70. PubMed ID: 21602471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
    Sadoshima S; Fujii K; Ooboshi H; Ibayashi S; Fujishima M
    Stroke; 1993 Oct; 24(10):1561-6; discussion 1566-7. PubMed ID: 8378962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
    Inada Y; Tanabe M; Kawazoe K; Nishikawa K
    Jpn J Pharmacol; 1988 Jul; 47(3):311-22. PubMed ID: 2851677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.
    Costall B; Domeney AM; Gerrard PA; Horovitz ZP; Kelly ME; Naylor RJ; Tomkins DM
    Pharmacol Biochem Behav; 1990 May; 36(1):13-20. PubMed ID: 2112256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.
    Costall B; Coughlan J; Horovitz ZP; Kelly ME; Naylor RJ; Tomkins DM
    Pharmacol Biochem Behav; 1989 Jul; 33(3):573-9. PubMed ID: 2685828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.